Methods in Cancer Stem Cell Biology

Said M Afify

Department of Oncology, Lombardi Comprehensive Cancer, Georgetown University, Washington, DC, USA.

Division of Biochemistry, Chemistry Department, Faculty of Science, Menoufia University, Egypt.

Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Japan.

Dr said M. Afify received his PhD in Cancer Biology from Okayama University, Japan in 2019. With the support of the Japan Society for the Promotion of Science (JSPS) 2020, he conducted his first postdoctoral research at Okayama University. Currently, he is a cancer biologist at the Lombardi Comprehensive Cancer Center at Georgetown University in Washington, DC. Through this role, he continues to contribute to cancer research, building upon his previous experience. In order to improve our understanding and treatment of cancer, he works closely with leading experts in the field and conducts cutting-edge research. He works with a dedicated team of researchers at the Lombardi Comprehensive Cancer Center. With his expertise and passion for science, he hopes to make a significant impact on the fight against cancer and improve patient lives.

Masaharu Seno

Professor, Laboratory of Nano-Biotechnology, Division of Biotechnology and Medicine, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Japan.

Professor Masaharu Seno is a professor emeritus at Okayama University. His PhD was awarded from Osaka University in 1989. He worked as a scientist for Takeda Chemical Industries for 10 years. Since 1992, he has been working at Okayama University. His current research is focusing on the induction of cancer stem cells from normal pluripotent stem cells. His research work was awarded from Kudoh Foundation of Cancer Research in1993 and from Okayama Foundation for Science and Technology in1995. Developing novel cancer stem cell models, Professor Seno is currently investigating the process of carcinogenesis under cancer inducing niches as well as plasticity, metastasis and invasion of cancer stem cells including the development of novel cancer treatments.

Said M Afify
肿瘤学系，Lombardi Comprehensive Cancer，乔治城大学，华盛顿特区，美国。
生物化学部，理学院，Menoufia大学，埃及。
健康系统跨学科科学与工程研究生院，冈山大学，日本。
Said M. Afify博士于2019年在日本冈山大学获得癌症生物学博士学位。在日本学术振兴会（JSPS）2020年的支持下，他在冈山大学进行了他的第一份博士后研究。目前，他是华盛顿特区乔治城大学Lombardi Comprehensive Cancer Center的癌症生物学家。通过这个角色，他继续为癌症研究做出贡献，借鉴他以前的经验。为了改善我们对癌症的理解和治疗，他与该领域的领先专家密切合作，并进行尖端研究。他与Lombardi Comprehensive Cancer Center的一支专业团队合作。凭借他的专业知识和对科学的热情，他希望在与癌症的斗争中产生重大影响，并改善患者的生活。

Masaharu Seno
纳米生物技术实验室，生物技术与医学部，健康系统跨学科科学与工程研究生院，冈山大学，日本。
Masaharu Seno教授是冈山大学的名誉教授。他于1989年从大阪大学获得博士学位。他曾在武田药品工业公司担任科学家长达10年。自1992年以来，他一直在冈山大学工作。他目前的研究重点是从正常多能干细胞诱导癌症干细胞。他的研究工作于1993年获得了Kudoh癌症研究基金会的奖励，并于1995年获得了冈山科学技术基金会的奖励。通过开发新型癌症干细胞模型，Seno教授目前正在研究癌症诱导微环境下的癌症发生过程，以及癌症干细胞的可塑性、转移和侵袭，包括新型癌症治疗的开发。